Compare Invesco WilderHill Clean Energy ETF (PBW) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Invesco WilderHill Clean Energy ETF vs TransMedics Group Inc — how do they compare? Invesco WilderHill Clean Energy ETF trades at $28.33 (market cap $335.90M), while TransMedics Group Inc trades at $77.87 (market cap $2.74B). The key difference: TransMedics Group Inc is far larger — about 8.2× Invesco WilderHill Clean Energy ETF's market cap, and TransMedics Group Inc is trading nearer its 52-week high, Invesco WilderHill Clean Energy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Invesco WilderHill Clean Energy ETF for 46 Days and TransMedics Group Inc for 24 Days on average.
| PBW | TMDX | |
|---|---|---|
Market Cap | $335.90M | $2.74B |
Volume | 628,890 | 949,331 |
Sector | Sector/Thematic | Health |
52-Week High | $46.99 | $150.42 |
52-Week Low | $28.29 | $61.99 |
Typical Hold Time | 46 Days | 24 Days |
Enterprise Value | — | $3.13B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
PBW (Invesco WilderHill Clean Energy ETF) trades at $28.33, down 2.04% with a bearish technical signal. The ETF's unique selection criteria prioritize ecological factors over financial metrics, resulting in concentrated exposure to clean energy companies. Recent institutional selling by IFP Advisors (-96.3% position) reflects caution amid sector volatility. Technical indicators show mixed signals with neutral oscillators but bearish moving averages.
Clean energy ETFs face headwinds from oil price volatility and tech sector weakness, though long-term energy transition trends provide growth potential. Key risks include undiversified portfolio concentration, geopolitical energy market impacts, and Federal Reserve policy uncertainty. The ETF's performance remains tied to clean energy adoption rates and government policy support.
TransMedics Group (TMDX) trades at $77.87, down 3.95% on the day, amid a bearish technical signal and recent earnings misses. The company maintains strong profitability with a 22.69% net income margin and 36.28% ROE, though 2026 projections show margin compression. Analyst consensus remains bullish with a $99.75 price target, but sentiment is clouded by multiple legal investigations into fiduciary duties announced in late August and September 2026.
The stock faces near-term pressure from technical weakness and legal overhangs, but solid fundamentals and analyst conviction suggest long-term potential if execution improves. Key risks include ongoing legal scrutiny, margin pressures from heavy investment, and volatility around future earnings reports.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Invesco WilderHill Clean Energy ETF
PBW is an equal-weighted ETF that invests in U.S. companies leading the clean energy transition. It focuses on renewable energy, power conservation, and sustainable technologies like solar, wind, and energy storage.
Read more on PBW →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
